 |
Julphar sees market growth this yearThe UAE-based Julphar, a leading pharmaceutical company in the region, expects the regional market to improve this year. “Despite the difficult and uncertain times in the regional economic cycle, overall, the company is expe More… |
|
Julphar sees market growth this yearThe UAE-based Julphar, a leading pharmaceutical company in the region, expects the regional market to improve this year. “Despite the difficult and uncertain times in the regional economic cycle, overall, the company is expe More… |
 |
Julphar CEO to leave in Q2Julphar chief executive officer Dr Ayman Sahli has decided to leave the company in the second quarter of this year, when his contract expires. The Julphar board said it respects his wishes and has accepted his decision. The process to s More… |
 |
Julphar posts $207m revenue in H1UAE-based Julphar Gulf Pharmaceutical Industries, a leading generic pharmaceutical manufacturer in Mena, announced sales revenue of Dh759.7 million ($206.8 million) in the first half of this year. The company posted a gross profit More… |
|
Julphar posts $207m revenue in H1UAE-based Julphar Gulf Pharmaceutical Industries, a leading generic pharmaceutical manufacturer in Mena, announced sales revenue of Dh759.7 million ($206.8 million) in the first half of this year. The company posted a gross profit More… |
 |
Pharma and tech join to fight diseaseThe line between pharmaceuticals and technology is blurring as companies join forces to tackle chronic diseases using high-tech devices that combine biology, software and hardware. GlaxoSmithKline and Google parent Alphabet are th More… |
 |
Novartis splits drugs business into twoNovartis is splitting its pharmaceuticals division into two business units, one focused on cancer and the second on other drugs, while switching out its current pharma head in the second high-profile management reshuffle this year. More… |
 |
Julphar sales total $400m in 2015Ras Al Khaimah-based Julphar (Gulf Pharmaceutical Industries) recorded sales totalling Dh1.47 billion ($400.11 million) in 2015, an increase of 6 per cent compared to the previous year, it was revealed at the company’s general assembly rec More… |
|
Julphar sales total $400m in 2015Ras Al Khaimah-based Julphar (Gulf Pharmaceutical Industries) recorded sales totalling Dh1.47 billion ($400.11 million) in 2015, an increase of 6 per cent compared to the previous year, it was revealed at the company’s general assembly rec More… |
 |
Pacific free trade pact near dealA dozen Pacific nations closed in on a sweeping free trade pact on Sunday in Atlanta after a breakthrough over how long a monopoly pharmaceutical companies should be given on new biotech drugs. The issue has pitted the United Stat More… |
